PEPG (pepgen.com) Bozor qiymatining balans qiymatiga nisbati
GURU.Markets platformasidagi ushbu kunlik narxlar grafigi PepGen Inc. (PEPG) kompaniyasining narxlar dinamikasini aks ettiradi, uning biznes modeli yopiq patent sikliga ega EDO tizimi orqali mushak patologiyalari uchun RNK terapiyasiga asoslangan. PepGen Inc. (PEPG) noyob genetik kasalliklarga qarshi kurashish uchun zararlangan to'qimalarga dori vositalarini yetkazib berishning ilg'or usullarini joriy qilmoqda. Ko'rsatkich 1.45 darajasida turibdi, qimmat klinika sinovlari va FDA nazorati esa raqobatchilarga qarshi himoya to'sig'ini yaratadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_PEPG_-_PepGen-Inc._-_Capitalization-to-Book-Value-Ratio "PEPG PepGen Corp Bozor kapitallashuvining balans qiymatiga nisbati (28.04.2023 - 27.10.2026) | 👁️GURU.Markets👁️")
PepGen Inc. (PEPG) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Fundamental baholash:PEPG PepGen Inc
PepGen Inc. klinik sinovlar natijalariga yuqori bog'liqlikka ega bo'lgan tipik biotexnologiya startapidir. Kompaniyaning joriy P/B koeffitsiyentini tahlil qilib, investor sof aktivlar qiymatidan yuqori bo'lgan bozor premiumini ko'radi. Ushbu koeffitsient biznesning bozor qiymatini uning balans qiymati bilan solishtirib, kelajakdagi muvaffaqiyatlarga nisbatan bozor kutganlarini o'lchaydi. PepGen Inc. (PEPG) uchun ushbu metrika daromad mavjud bo'lmagan holatda intellektual mulkning qiymatini aks ettiradi. Ushbu tendentsiyaning barqarorligi intensiv R&D xarajatlari fonida naqd pul rezervlarini boshqarishning adekvatligini tasdiqlaydi.
Raqobatchilar tahlili
Bozor kapitallashuvining balans qiymatiga nisbati BIIB (Biogen Inc.)|NBIX (neurocrine.com) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|BHVN (Biohaven Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals AMLX|Sof aktivlarga nisbatan bozor kapitallashuvi trevitherapeutics.com|Praxis Precision Medicines, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti AVXL (Anavex)|CeriBell Corp (CBLL) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Prothena PRTA|Bozor kapitallashuvining balans qiymatiga nisbati ALEC|ANNX - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati OMER|NGNE (Neurogene Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati AC Immune Corp (ACIU)|Kapitallashuvning balans qiymatiga nisbati Voyager Corp (VYGR)|Neumora Therapeutics (NMRA) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati scilexholding.com (SCLX)|Bozor kapitallashuvining balans qiymatiga nisbati TVGN|Alpha Cognition Inc - Balans qiymatiga nisbatan bozor kapitallashuvi|Cognition Therapeutics, Inc. (CGTX) - Bozor qiymatining balans qiymatiga nisbati|IKT - Kapitallashuvning balans qiymatiga nisbati|SAVA (Cassava Sciences, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Assertio|COYA: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi VTGN|OVID - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Acumen Pharmaceuticals, Inc (ABOS)|CRVO: Bozor kapitallashuvining balans qiymatiga nisbati|Alterity Therapeutics Ltd. - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Clene Nanomedicine|JUNS - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati RLMD (Relmada)|ANVS (Annovis Bio Corporation) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Grace Therapeutics Inc (GRCE)|Kapitallashuvning balans qiymatiga nisbati fireflyneuro.com|Klotho Neurosciences Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neurosense-tx.com NRSN|Kapitallashuvning sof aktivlarga nisbati RVPH (Reviva Pharmaceuticals Holdings)|MetaVia Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NeurAxis, Inc. (NRXS)|HSDT: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati PASG|NEUP (Neuphoria Therapeutics) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Minerva Neurosciences Corp NERV|Sof aktivlarga nisbatan bozor kapitallashuvi Athira Pharma Corp|Addex Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ALZN (alzamend.com)|Cyclerion Therapeutics, Inc. (CYCN) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Protagenic Therapeutics Inc. PTIX|Bozor kapitallashuvining balans qiymatiga nisbati KTTA|CRGT - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATXI|BCLI (brainstorm-cell.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics (CARA)|Kapitallashuvning balans qiymatiga nisbati Chromocell Therapeutics Corp (CHRO)|Eliem Therapeutics (ELYM) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati intracellulartherapies.com (ITCI)|Bozor kapitallashuvining balans qiymatiga nisbati LBPH|marinuspharma.com - Balans qiymatiga nisbatan bozor kapitallashuvi|NKGen Biotech (NKGN) - Bozor qiymatining balans qiymatiga nisbati|NRBO - Kapitallashuvning balans qiymatiga nisbati|SAGE (Sage Therapeutics, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Synaptogenix, Inc|TRVN: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi VIGL|WENA - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Cerevel Therapeutics Inc (CERE)